Liraglutide generic?

Short answer:
No, a fully approved generic version of liraglutide (the active ingredient in Victoza®, Saxenda®, and other GLP‑1 products) is not yet available in most markets. The drug is still sold under its brand name, and generic approval is still pending in many countries.

Why that’s the case:
Liraglutide is a peptide drug that requires a very specific manufacturing process and formulation to keep it stable and effective. Because of this, the patent and regulatory hurdles make it more challenging to bring a generic version to market compared with small‑molecule drugs.

What you can do instead:

| Option | What it means | How to get it |
|--------|--------------|--------------|
| Brand‑name liraglutide | Same active ingredient, usually the most reliable choice. | Check if your insurance covers Victoza® or Saxenda®. |
| Other GLP‑1 agonists | Similar mechanism of action (e.g., semaglutide – Ozempic®, Rybelsus®; dulaglutide – Trulicity®). | Ask your provider if a different GLP‑1 might be appropriate. |
| Patient assistance programs | Many manufacturers run programs that can reduce or waive copays. | Visit the company’s website or call customer service. |
| Clinical trials | Some studies offer free access to liraglutide. | Look up clinicaltrials.gov or ask your doctor. |
| Generic status updates | New generic approvals can happen; check the FDA (USA) or EMA (EU) databases periodically. | Search “liraglutide generic” on the agency’s website. |

Key take‑away:
While no generic liraglutide is currently approved, you still have options to manage your treatment—either by staying with the branded product (possibly with assistance) or switching to a different GLP‑1 agonist that fits your needs and budget. If cost is a major concern, discuss all these alternatives with your prescriber; they can help you find the best, most affordable option.